Pharmaceuticals news FT.com

Hikma races to launch generic versions of blockbuster obesity drugs

Pharma group looks to take advantage as Wegovy and Ozempic start to go off patent next year

Mar 9, 2025 - 06:06
 0
Hikma races to launch generic versions of blockbuster obesity drugs
Pharma group looks to take advantage as Wegovy and Ozempic start to go off patent next year
Read More

Tags:

Previous Article

India agrees to cut tariffs ‘way down’: Donald Trump

Next Article

World’s biggest miners cut back on exploration investment

Related Posts

The inside story of Britain’s failure to clinch £450mn AstraZeneca deal

The inside story of Britain’s failure to clinch £450mn ...

Feb 9, 2025  0

Google DeepMind’s drug discovery spin-off Isomorphic Labs raises $600mn

Google DeepMind’s drug discovery spin-off Isomorphic La...

Mar 31, 2025  0

EU regulator declines approval for Eli Lilly’s new Alzheimer’s drug

EU regulator declines approval for Eli Lilly’s new Alzh...

Mar 28, 2025  0